My Ovarian Cancer has spread to my bones — how is this treated

Ovarian Cancer with Bone Metastases: Treatment Approaches

I'm glad you're seeking to understand your situation better. Bone metastases (cancer that has spread to the bones) from ovarian cancer represent advanced disease, but there are several treatment approaches your oncology team may consider.

How Doctors Approach Bone Metastases from Ovarian Cancer

When ovarian cancer spreads to bone, oncologists typically think about this as systemic disease — meaning the cancer is throughout your body, not just in one spot. This understanding shapes treatment strategy. Your care team will consider:

• Your overall health and performance status (how well you're functioning)
• Which bones are affected and how many sites
• Whether you've had prior treatments and how your cancer responded
• Your specific tumor characteristics (genetic mutations, hormone receptor status, etc.)
• Symptom management (pain control is important)

General Treatment Approaches

1. Systemic Chemotherapy Standard first-line treatment typically includes platinum-based chemotherapy (like carboplatin) combined with taxane drugs (like paclitaxel). This addresses cancer throughout your body, including bone lesions.

2. Targeted Therapies Based on Your Tumor's Genetics According to the CancerPatientLab webinars on precision medicine, ovarian cancer oncologists are very open to functional tumor testing to identify which drugs your specific cancer responds to best. This is particularly important because:

• If you have a BRCA mutation (germline or somatic), PARP inhibitors (like olaparib or niraparib) may be recommended, either as maintenance therapy after chemotherapy or in combination with chemotherapy
• Other genetic mutations (like KRAS, TP53, or homologous recombination deficiency) may point toward specific targeted drugs
• Functional precision oncology testing — where your actual tumor tissue is tested against multiple drugs — can help identify which treatments your cancer is most likely to respond to

3. Maintenance Therapy After initial chemotherapy response, maintenance treatments may include:

• PARP inhibitors (if you have HRD/BRCA status)
• Bevacizumab (an anti-angiogenic drug that cuts off blood supply to tumors)
• Combinations of these approaches

4. Radiation Therapy For specific bone lesions causing pain or structural problems, targeted radiation may be considered to:

• Reduce pain
• Prevent fractures
• Treat lesions that aren't responding to systemic therapy

5. Supportive Care

• Bone-strengthening medications (bisphosphonates or denosumab) to reduce fracture risk
• Pain management strategies
• Physical therapy when appropriate

The Importance of Tumor Testing

Here's something important: Don't assume standard treatment is your only option. According to Dr. [removed] Apfel's webinar on precision oncology, ovarian cancer surgeons and oncologists are particularly receptive to functional tumor testing because:

"For ovarian cancer, the ovarian cancer oncologists and surgeons are very open to that, because they know the situation. They have access to the tissue, but they often also do the chemotherapy or targeted therapies, let's say PARP inhibitors, for patients with BRCA mutations."

If you have upcoming surgery or a biopsy, you could discuss with your team whether functional profiling of your tumor tissue might be valuable. This requires only about 100 milligrams of tissue and can be done from:

• Surgical specimens
• Biopsies
• Fluid samples (ascites or pleural effusion) if you have fluid buildup

Results typically come back in 1-2 weeks and can help guide which drugs are most likely to work for YOUR specific cancer.

Questions to Ask Your Oncology Team

1. What is my tumor's genetic profile? (BRCA status, HRD status, other mutations)
2. Have you considered functional tumor testing to identify which drugs my cancer responds to? If not, why not?
3. What is the recommended first-line treatment for my specific situation, and why?
4. If I have a BRCA mutation or HRD, what role will PARP inhibitors play in my treatment plan?
5. What is the goal of treatment? (Cure, remission, symptom control, life extension?)
6. How will we monitor response? (Imaging schedule, tumor markers like CA-125)
7. What side effects should I expect, and how will we manage them?
8. Are there clinical trials appropriate for my situation?
9. What supportive care (bone health, pain management) should we prioritize?

Important Context

According to NCCN Guidelines for ovarian cancer, treatment decisions depend heavily on:

• Stage and extent of disease
• Histologic type (epithelial, germ cell, etc.)
• Prior treatments
• Your performance status and preferences

The fact that your cancer has spread to bone doesn't mean treatment won't work — many patients with metastatic ovarian cancer achieve significant responses and extended survival with modern approaches, particularly when treatment is tailored to their tumor's specific characteristics.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.